Local News: Ashburn, VA 

 | 

Sign Up

 | 

Sign In

Psoriasis News Editors

News Widget

Display the Psoriasis news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Psoriasis News

News on Psoriasis continually updated from thousands of sources around the net.

Tuesday May 14 | MediLexicon

Creabilis Announces Headline Results Of Its Phase 2b Trial Of Topical TrkA Kinase Inhibitor CT327

Clinically and Statistically Significant Reduction of Chronic Pruritus Seen in Psoriasis Patients Creabilis, a late stage European dermatology company with a focus on chronic pruritus , has announced headline results of its Phase 2b trial with its lead product, CT327, in psoriasis patients.

Comment?

Related Topix: Medicine, Health, Dermatology

Fri May 10, 2013

Townhall

Crista Huff: Stocks in the News: Sotheby's, Celgene, Nvidia

Stocks in the News is produced by Ransom Notes Radio and Goodfellow, LLC . Crista Huff manages Goodfellow LLC, a website that recommends outperforming stocks using fundamental and technical analysis.

Comment?

Related Topix: Financial Markets, Biotech, Celgene, Medicine, Healthcare Industry, Opinion

Sys-Con Media

Creabilis Announces Headline Results of its Phase 2b Trial of Topical TrkA Kinase Inhibitor CT327

Creabilis, a late stage European dermatology company with a focus on chronic pruritus , today announces headline results of its Phase 2b trial with its lead product, CT327, in psoriasis patients.

Comment?

Related Topix: Medicine, Dermatology, Health

Wed May 08, 2013

Business Journal

Idera stock up on positive psoriasis drug data

Idera Pharmaceuticals released positive data on its Phase 2 trial of IMO-3100, a candidate for the treatment of psoriasis, an autoimmune disease that results in inflammation of the skin and join problems and is linked with other conditions such as diabetes, heart disease and depression.

Comment?

Related Topix: Medicine, Health, Biotech, Idera Pharmaceuticals, Cambridge, MA

Tue Apr 30, 2013

The Lake Stevens Journal Online

Local student walks for awareness

Rashes and lesions on the skin are common symptoms of psoriasis, an autoimmune disease that often gets mistaken for eczema.

Comment?

Sun Apr 28, 2013

CBS Local

Miss California USA 2013 Discusses Her Battle With Psoriasis

Psoriasis is reportedly the most prevalent autoimmune illness in the U.S. and the National Psoriasis Foundation is leading the charge to find a cure for the skin disease.

Comment?

Related Topix: Medicine, Health

Express India

Biocon to launch psoriasis drug novel biologic in July

Biotechnology major Biocon plans to launch in July its novel biologic drug Itolizumab branded as 'Alzumab' to be used for the treatment of chronic plaque psoriasis in the country.

Comment?

Related Topix: Medicine

Fri Apr 26, 2013

BioSpace

Ingredient in New MS Drug Linked to Serious Brain Disease, The New...

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! The active ingredient in a drug that's expected to become a popular treatment for multiple sclerosis has been linked to four European cases of a rare but sometimes fatal brain disease called progressive multifocal leukoencephalopathy .

Comment?

Related Topix: Medicine, Multiple Sclerosis, Health

Thu Apr 25, 2013

Patch.com

Local Study Finds Synthetic Vitamin D Might Ease Liver Disease

A synthetic form of Vitamin D might ease the impact of chronic liver disease, the Salk Institute for Biological Studies announced Thursday.

Comment?

Related Topix: Vitamin D, Supplement, Hepatitis, Medicine, Alcoholism

Wed Apr 24, 2013

The Washington Post

Psoriasis Drug Similar to Biogen's BG-12 Linked to Brain Disease

Biogen Idec Inc.'s Fumaderm, an early formulation of the company's just approved multiple sclerosis pill Tecfidera, was tied to three cases of a brain infection more often linked to its potent medication Tysabri.

Comment?

Related Topix: Medicine, Business News